GlassScriptPhysician profile
Pooja Sodha
NPI 1821380171
$11,445.42
in general payments reported to CMS, 2019-2025
28 companies · $2,167 in 2025
The $2,167 reported for 2025 was more than what 78% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $125 · 2020: $4,109 · 2021: $271 · 2022: $960 · 2023: $1,518 · 2024: $2,295 · 2025: $2,167.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,981.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,980.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solta Medical, A Division of Bausch Health US, LLC | $4,044.69 | 2020-2025 | Fraxel, Clear & Brilliant |
| Abbvie INC. | $1,280.75 | 2020-2025 | Rinvoq |
| Novartis Pharmaceuticals Corporation | $838.78 | 2021-2025 | |
| Amgen INC. | $680.64 | 2022-2025 | Otezla, Otezla, Enbrel |
| Ucb, INC. | $671.08 | 2022-2025 | Bimzelx, Cimzia, Briviact |
| E.R. Squibb & Sons, L.L.C. | $619.34 | 2022-2025 | Sotyktu |
| Janssen Biotech, INC. | $403.21 | 2022-2025 | Tremfya, Simponi Aria, Simponi |
| Pfizer INC. | $402.12 | 2021-2025 | |
| Genzyme Corporation | $365.52 | 2022-2025 | |
| Lilly USA, LLC | $337.06 | 2021-2025 | Taltz, Ebglyss, Olumiant |
| Sun Pharmaceutical Industries INC. | $261.75 | 2022-2025 | Odomzo, Blu-U |
| Galderma Laboratories, L.P. | $232.96 | 2020-2025 | Nemluvio, Aklief, Epsolay |
| Arcutis Biotherapeutics, INC. | $213.27 | 2023-2025 | Zoryve |
| Regeneron Healthcare Solutions, INC. | $189.57 | 2021-2024 | Dupixent, Libtayo |
| Incyte Corporation | $163.12 | 2021-2024 | Opzelura |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Leo Pharma INC. | $162.82 | 2020-2025 | Adbry, Anzupgo |
| Allergan, INC. | $125.00 | 2019 | |
| Dermavant Sciences, INC. | $78.27 | 2023-2024 | Vtama |
| Organon LLC | $62.16 | 2023-2024 | Hadlima |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $57.83 | 2021-2023 | Jublia, Arazlo, Bryhali |
| Kyowa Kirin, INC. | $54.94 | 2023-2024 | Poteligeo |
| Vyne Pharmaceuticals INC. | $53.34 | 2020 | |
| Almirall LLC | $41.62 | 2022-2024 | Klisyri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $33.55 | 2025 | Spevigo |
| Biocon Biologics INC | $23.08 | 2024 | Hulio |
| Alnylam Pharmaceuticals INC. | $17.34 | 2023 | Givlaari |
| Astrazeneca Pharmaceuticals LP | $16.93 | 2023 | Saphnelo |
| Tactile Systems Technology INC | $14.68 | 2024 | Flexitouch Plus, Entre Plus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pooja Sodha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.